The Innovative Medicines Initiative (IMI) is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI has launched IMI2 – Call 12, with topics on Alzheimer, data, Sjögren’s Syndrome, vaccines, the blood-brain barrier, & a European Screening Centre. Stage 1 submission deadline: 24 October 2017 Stage 2 […]
